Oral Nutritional Supplement Effect on HDL Function

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

December 30, 2023

Conditions
HDL
Interventions
DIETARY_SUPPLEMENT

CardioLux™HDL

"Enrollment will occur according to the inclusion/ exclusion criteria and after the review and signing of the Informed Consent form. Clinical testing will be performed at baseline and each visit (2, 3).~Measurement of height, weight with body composition analysis, body mass index, waist circumference, and vital signs (blood pressure, heart rate) will be measured.~Review of medical history and current medications by clinician; and collection of fasting blood for testing of the complete blood count (CBC), comprehensive metabolic profile (CMP), as well as a urine pregnancy test in females of child-bearing potential.~Visits: Baseline (Visit 1), Week 6 (Visit 2) and Week 12 (Visit 3/End of Study)"

DIETARY_SUPPLEMENT

Placebo

"Enrollment will occur according to inclusion /exclusion criteria and after the review and signing of the Informed Consent form. Clinical testing will be performed at baseline and each visit (2, 3).~Measurement of height, weight with body composition analysis, body mass index, waist circumference, and vital signs (blood pressure, heart rate) will be measured.~Review of medical history and current medications by clinician; and collection of fasting blood for testing of the complete blood count (CBC), comprehensive metabolic profile (CMP), as well as a urine pregnancy test in females of child-bearing potential.~Visits: Baseline (Visit 1), Week 6 (Visit 2) and Week 12 (Visit 3/End of Study)"

Trial Locations (1)

37205

Hypertension Institute, Nashville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Metagenics, Inc.

INDUSTRY

NCT04529174 - Oral Nutritional Supplement Effect on HDL Function | Biotech Hunter | Biotech Hunter